Rebecca Maloney

Title: Rebecca Maloney: Innovator in Genetic Research

Introduction

Rebecca Maloney is a prominent inventor based in Centreville, Virginia. She has made significant contributions to the field of genetic research, particularly in understanding gene expression and cancer diagnosis. With a total of two patents to her name, her work has the potential to impact clinical practices and improve patient outcomes.

Latest Patents

Rebecca's latest patents include groundbreaking inventions related to single nucleotide polymorphisms (SNPs). One patent describes the use of SNPs and combinations of novel and known polymorphisms for determining the allele-specific expression of the IGF2 gene. This innovation is crucial for understanding gene function and its implications in various health conditions. Another patent focuses on gene methylation in cancer diagnosis. It provides DNA biomarker sequences that are differentially methylated in samples from normal individuals and those with cancer. This invention offers methods for identifying these biomarker sequences, which can be instrumental in the detection and diagnosis of cancer.

Career Highlights

Rebecca is currently associated with Orion Genomics LLC, where she continues to advance her research in genetics. Her work at the company emphasizes the importance of genetic markers in clinical settings, paving the way for more personalized medicine approaches.

Collaborations

Rebecca has collaborated with notable professionals in her field, including Muhammad A Budiman and Jeffrey A Jeddeloh. These collaborations have further enriched her research and contributed to the development of innovative solutions in genetic diagnostics.

Conclusion

Rebecca Maloney's contributions to genetic research through her patents highlight her role as an influential inventor in the field. Her work not only enhances our understanding of gene expression but also holds promise for improving cancer diagnosis and treatment.